Trials / Conditions / Adenomatous Polyposis Coli

Adenomatous Polyposis Coli

12 registered clinical trials studyying Adenomatous Polyposis Coli — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Cold Atmospheric Plasma for the Endoscopic Treatment of Duodenal Polyps in Patients With Familial Adenomatous NCT06435533	Universitätsklinikum Hamburg-Eppendorf	N/A
Completed	A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis NCT05014360	Janssen Research & Development, LLC	Phase 1
Completed	A Study of Guselkumab in Participants With Familial Adenomatous Polyposis NCT03649971	Janssen Research & Development, LLC	Phase 1
Completed	Sirolimus and Familial Adenomatous Polyposis (FAP) NCT03095703	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	Phase 2
Withdrawn	Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics NCT03027401	National Cancer Institute (NCI)	—
Completed	Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW NCT02113202	University Medical Center Groningen	Phase 1
Completed	Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients NCT01604564	Universitaire Ziekenhuizen KU Leuven	—
Completed	A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients NCT01187901	University of Utah	Phase 2
Terminated	Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP) NCT00585312	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3
Unknown	Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatou NCT00319007	Radboud University Medical Center	Phase 2
Terminated	A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED) NCT00140894	Merck Sharp & Dohme LLC	Phase 4
No Longer Available	Post-Trial Access for Guselkumab in Participants With Familial Adenomatous Polyposis NCT04948398	Janssen Research & Development, LLC	—